Figure S2. Clinical characteristics of the ESCC patients with TP53 mutations (G245C and R273H) in smokers and non-smokers (Fisherâs exact test, Pâ=â0.107). (TIF 8844 kb
Baseline characteristics of patient 78. Table S2. List of patients ordered on the basis of circPVT1 ...
Table S4. Significantly mutated gene test by MuSiC2. TP53 and FANCC were shown to have the highest n...
Tumor formation by p53 -/- ; Tsc1 -/- or p53 -/- ; Tsc1 -/+ cells in wild-type (WT) and BALB/c nude ...
Figure S1. G245C and R273H reduced IR-induced apoptosis and weakened cell cycle arrest. (A) The port...
Figure S8. The effects of TP53, ZNF750, CDC27 and other clinical features on the activity of the “Np...
Figure S1. Significantly mutated genes in 302 ESCC. The samples are sorted by the counts of somatic ...
Figure S1. The number of mutations per EAC case from different EAC subtypes. (TIFF 98 kb
Figure S3. Population stratification of 302 ESCC patients. Two hundred eight genotyped reference ind...
Table S3. Driver gene analysis by MutSig. The two genes with q value <â10â3 (TP53 and FANCC, hig...
Univariate analyses and multivariate analysis of factors associated with overall survival for ESCC p...
Association between clinicopathological data and SOX2 gene status in NSCLC tumors. (PDF 101Â kb
A Baseline NRG1 level in archival tumor samples by treatment group and indication. B Best percentage...
Table S2. Pathogenic and likely pathogenic mutations identified in the studied cohort. Annotations a...
Sensitivity analysis (allele C vs. G) of TP53 rs1042522 and OL risk. (TIF 358 kb
Figure S2. Kaplan-Meier curves of OS stratified by PIK3CA mutation. PIK3CA mutant tumors (solid) and...
Baseline characteristics of patient 78. Table S2. List of patients ordered on the basis of circPVT1 ...
Table S4. Significantly mutated gene test by MuSiC2. TP53 and FANCC were shown to have the highest n...
Tumor formation by p53 -/- ; Tsc1 -/- or p53 -/- ; Tsc1 -/+ cells in wild-type (WT) and BALB/c nude ...
Figure S1. G245C and R273H reduced IR-induced apoptosis and weakened cell cycle arrest. (A) The port...
Figure S8. The effects of TP53, ZNF750, CDC27 and other clinical features on the activity of the “Np...
Figure S1. Significantly mutated genes in 302 ESCC. The samples are sorted by the counts of somatic ...
Figure S1. The number of mutations per EAC case from different EAC subtypes. (TIFF 98 kb
Figure S3. Population stratification of 302 ESCC patients. Two hundred eight genotyped reference ind...
Table S3. Driver gene analysis by MutSig. The two genes with q value <â10â3 (TP53 and FANCC, hig...
Univariate analyses and multivariate analysis of factors associated with overall survival for ESCC p...
Association between clinicopathological data and SOX2 gene status in NSCLC tumors. (PDF 101Â kb
A Baseline NRG1 level in archival tumor samples by treatment group and indication. B Best percentage...
Table S2. Pathogenic and likely pathogenic mutations identified in the studied cohort. Annotations a...
Sensitivity analysis (allele C vs. G) of TP53 rs1042522 and OL risk. (TIF 358 kb
Figure S2. Kaplan-Meier curves of OS stratified by PIK3CA mutation. PIK3CA mutant tumors (solid) and...
Baseline characteristics of patient 78. Table S2. List of patients ordered on the basis of circPVT1 ...
Table S4. Significantly mutated gene test by MuSiC2. TP53 and FANCC were shown to have the highest n...
Tumor formation by p53 -/- ; Tsc1 -/- or p53 -/- ; Tsc1 -/+ cells in wild-type (WT) and BALB/c nude ...
DOI
Add to ORKG